Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up

Haematologica

Volumn 86, Issue 3, 2001, Pages 291-296

  Lorenzo, J I ^a   Moscardo F ^a   Lopez Aldeguer J ^a   Aznar, J A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

AIDS; Hemophilia; HIV infection; Risk factors

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE; ARTICLE; DISEASE COURSE; FOLLOW UP; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; RISK FACTOR; SEROCONVERSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEMOPHILIA A; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; INFANT; MIDDLE AGED;

EID: 0035070071     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Changes in longevity and causes of death among persons with hemophilia A
2. The natural history of human immunodeficiency virus infection in a hemophilic cohort
3. The progression of HIV disease in a hemophilic cohort followed for 12 years
4. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia
5. Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs
6. HEMOCO: A French prospective study of hemophiliacs infected by human immunodeficiency virus type 1 (HIV-1)
7. Progression of HIV infection in a cohort of hemophiliacs over an 11-year period
8. Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patients
9. HIV-disease progression in Swedish haemophiliacs and the influence of replacement therapy
10. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion
11. The effect of CMV infection on progression of human immunodeficiency virus disease in a cohort of haemophilic men followed for up to 13 years from seroconversion
12. Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients
13. An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patients
14. Human immunodeficiency virus infection in hemophiliacs: Prevalence and current clinical situation
15. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
16. Mortality before and after HIV infection in the complete UK population of haemophiliacs
17. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study
18. The progression of HCV-associated liver disease in a cohort of haemophilic patients
19. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: Report on behalf of the directors of haemophilia centres in the United Kingdom
20. Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort
21. Human immunodeficiency virus infection in haemophiliacs in Taiwan: The importance of CD4 lymphocyte count in the progression to acquired immunodeficiency syndrome
22. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection
23. More rapid progression to AIDS in older HIV-infected people: The role of CD4+ T-cell counts
24. Inhibition of interleukin-2 secretion by factor VIII concentrates: A possible cause of immunodepression in haemophiliacs
25. Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: A possible cause of immunosuppression in haemophiliacs
26. A component of factor VIII preparations which can be separated from factor VIII activity down modulates human monocyte functions
27. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders
28. Effect of intermediate- and high-purity factor VIII concentrates on immune function in HIV-seropositive haemophiliacs as assessed by quantitative CD4 counts
29. The use of intermediate-purity clotting factor concentrates and HIV disease progression in men with haemophilia